Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

View:
Post by gravedigger51 on May 04, 2016 7:02am

M&A

Just reading now Pfizer is in the M&A mix as of yesterday.  Things are really heating up in pharma!

Then googled pharma short covering this morning.  Check out all the news on companies short covering over the last few days.

Hey shorts, come here and give me a big group hug, I love feeling the squeeze ;)

This was the third time in 9 months the shorts have gone after CXR.  What was all that talk in the Valeant Senate Committee about pigs and hogs?  Oink oink
Comment by 93Darkhorse93 on May 04, 2016 8:38am
This company is just a sitting duck.  No one wants to get in a bidding war for this asset.  All of their problems disappear within a large pharma company of PE firm.  If next weeks numbers are just not a disaster there is no reason for this to be trading in the low 30s. Cashflow is too appealing to ignore.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities